Dr_Tabb

Incoming Buying Opportunity

NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
REGN potentially coming into $460 range again.
R/R heavy in favor going long if it falls to this level.
Would keep watch.
Recent phase 3 results re:COVID19
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。